NDOR1: A Key Regulator of Neuronal Development and Function (G27158)

Target Name: NDOR1

NCBI ID: G27158

NDOR1

NDOR1: A Key Regulator of Neuronal Development and Function

Native Domain-Driven OR1 (NDOR1) is a protein that is expressed in various tissues throughout the body, including the nervous system, endocrine system, and gastrointestinal tract. It is a key regulator of neural development and function, and is involved in the regulation of a wide range of physiological processes that are critical for human health and disease.

The discovery of NDOR1 and its functions has significant implications for our understanding of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of neurons and their associated protein synthesis, leading to a range of symptoms that can include cognitive decline, muscle rigidity, and movement disorders.

NDOR1 has been shown to play a crucial role in the regulation of neurotransmitter release from neurons, which are responsible for transmitting electrical signals throughout the nervous system.NDOR1 has been shown to regulate the release of dopamine, a neurotransmitter that is involved in motor function and mood regulation, as well as the release of other neurotransmitters, such as GABA and serotonin.

In addition to its role in neurotransmitter regulation, NDOR1 is also involved in the regulation of cellular signaling pathways that are critical for neuronal function and development. Studies have shown that NDOR1 can interact with a wide range of protein partners, including tyrosine kinases, G protein-coupled receptors, and nuclear factor kappa B (NF-kappa-B), which are involved in the regulation of cellular signaling pathways that are critical for neuronal function and development.

The role of NDOR1 in neuronal function and development is also of great interest in the context of neurodegenerative diseases. In these conditions, the loss of neurons and their associated protein synthesis is thought to contribute to the progression of disease.NDOR1 has been shown to be involved in the regulation of neuronal function and development, and its dysfunction has been implicated in the development of neurodegenerative diseases.

In conclusion, the discovery of NDOR1 and its functions has significant implications for our understanding of neurodegenerative diseases. The regulation of neural development and function by NDOR1 is a critical factor in the regulation of a wide range of physiological processes that are essential for human health and disease. Further research is needed to better understand the role of NDOR1 in neurodegenerative diseases, and to develop effective treatments based on these discoveries.

Protein Name: NADPH Dependent Diflavin Oxidoreductase 1

Functions: NADPH-dependent reductase which is a central component of the cytosolic iron-sulfur (Fe-S) protein assembly (CIA) machinery (PubMed:10625700, PubMed:28648056, PubMed:23596212, PubMed:20802492, PubMed:15900210). Transfers electrons from NADPH via its FAD and FMN prosthetic groups to the [2Fe-2S] cluster of CIAPIN1, another key component of the CIA machinery (PubMed:28648056, PubMed:23596212, PubMed:20802492). In turn, this reduced cluster provides electrons for assembly of cytosolic iron-sulfur cluster proteins (PubMed:23596212, PubMed:20802492). It can also reduce the [2Fe-2S] cluster of CISD1 and activate this protein implicated in Fe/S cluster repair (PubMed:28648056). In vitro can fully activate methionine synthase/MTR in the presence of soluble cytochrome b5/CYB5A (PubMed:12871938)

The "NDOR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDOR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets